# Encompass Health Corporation (EHC) Stock Analysis: A 25% Upside Potential with Strong Buy Consensus

- Link: https://www.directorstalkinterviews.com/encompass-health-corporation-ehc-stock-analysis-a-25-upside-potential-with-strong-buy-consensus/4121256804
- Published: 2026-07-20T10:25:42+01:00
- Author: Madison Wilson

Investors seeking opportunities in the healthcare sector might find Encompass Health
Corporation (NYSE: EHC) to be a compelling option. As a leading provider in the 
medical care facilities industry, Encompass Health is focused on delivering specialized
rehabilitative treatment across the United States and Puerto Rico. The company’s
strategic operations and financial standing highlight a promising investment case,
especially with a 25.21% potential upside from its current stock price.

### Financial Performance and Valuation
 Encompass Health’s current stock price 
sits at $112.21, well within its 52-week range of $93.83 to $127.18. The company’s
market capitalization is a robust $11.13 billion, reflecting its significant presence
in the healthcare sector. Despite a minor price change of -0.28 in the latest session,
the stock maintains stability, supported by a forward P/E ratio of 17.17, indicating
moderate growth expectations and a reasonable valuation in the market.

### Revenue Growth and Profitability
 The company showcases an impressive revenue
growth rate of 9.00%, underscoring its ability to expand operations and capture 
additional market share. With an EPS of 5.83 and a remarkable return on equity of
25.23%, Encompass Health demonstrates strong profitability and efficient use of 
shareholder capital. These performance metrics indicate a healthy business model
capable of generating consistent returns.

### Dividend and Cash Flow Position
 For income-focused investors, Encompass Health
provides a dividend yield of 0.68%, supported by a conservative payout ratio of 
12.67%. This suggests a sustainable dividend policy, leaving ample room for reinvestment
and growth. Additionally, the company boasts a free cash flow of $284.1 million,
providing financial flexibility to fund strategic initiatives and enhance shareholder
value.

### Analyst Ratings and Price Targets
 The sentiment among analysts is overwhelmingly
positive, with 13 buy ratings and no hold or sell recommendations. The average target
price of $140.50 implies a potential upside of over 25% from the current levels,
with target prices ranging from $125.00 to $152.00. This bullish outlook reflects
confidence in the company’s growth prospects and operational execution.

### Technical Indicators
 From a technical perspective, Encompass Health is currently
outperforming key moving averages, with its 50-day moving average at $104.65 and
a 200-day moving average at $107.66. The Relative Strength Index (RSI) of 70.78 
suggests that the stock is nearing overbought territory, indicating strong momentum.
Meanwhile, the MACD of 2.47, above the signal line of 1.72, signals a bullish trend
continuation.

### Conclusion
 Encompass Health Corporation presents a compelling investment opportunity
with its strong operational performance, attractive valuation, and positive market
sentiment. The company’s strategic focus on high-demand rehabilitative services 
positions it well for future growth in the healthcare sector. With a 25% potential
upside and a strong buy consensus among analysts, Encompass Health is a noteworthy
consideration for investors seeking exposure to the healthcare industry.

Share on:
